Skip to main content
. 2013 Mar 7;110(12):4622–4627. doi: 10.1073/pnas.1210633110

Fig. 2.

Fig. 2.

PERK/UPR inhibition reduces the tumor hypoxic fraction. (A) Pimonidazole (pimo) immunohistochemistry (pimonidazole positive viable fraction, green; blood vessels, red; Hoechst dye, blue) and (B) H&E on U373 isogenic tumors. (C) Quantification of pimonidazole immunohistochemistry of the viable tumor tissue and (D) necrotic fraction.